Terminated PHASE3 INTERVENTIONAL 2-arm NCT01739556

On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction (PLATFORM)

Sponsor: Clinical Centre of Serbia

Conditions Acute ST-elevation Myocardial Infarction

Interventions Antiplatelet Regimen Modification (aspirin or ticagrelor)

Updated 8 times since 2017 Last updated: Jul 17, 2018 Started: Jun 30, 2015 Primary completion: Jan 31, 2018 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

An interim analysis showed that there is no difference in the primary endpoint, given the small number of events in the groups examined.

This PHASE3 trial investigates Acute ST-elevation Myocardial Infarction and is currently terminated or withdrawn. Clinical Centre of Serbia leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE3
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Aug 2018 — Nov 2020 [monthly]

Terminated PHASE3

Status: Recruiting → Terminated
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Centre of Serbia

Data source: Clinical Centre of Serbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belgrade, Serbia